Abcellera Biologics Inc
NASDAQ:ABCL
Abcellera Biologics Inc
Net Income (Common)
Abcellera Biologics Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Net Income (Common)
-$146.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Arch Biopartners Inc
XTSX:ARCH
|
Net Income (Common)
-CA$5.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-39%
|
|
Replicel Life Sciences Inc
XTSX:RP
|
Net Income (Common)
-CA$69.3k
|
CAGR 3-Years
69%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
Innovotech Inc
XTSX:IOT
|
Net Income (Common)
-CA$211.1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
14%
|
See Also
What is Abcellera Biologics Inc's Net Income (Common)?
Net Income (Common)
-146.4m
USD
Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Net Income (Common) amounts to -146.4m USD.